T-cell receptor-independent activation of clonal Th2 cells associated with chronic hypereosinophilia

Blood

Volumn 94, Issue 3, 1999, Pages 994-1002

  Roufosse, Florence ^b   Schandené, Liliane ^b   Sibille, Catherine ^b   Kennes, Bernard ^b   Efira, André ^b   Cogan, Elie ^b   Goldman, Michel ^a  

^a ERASME HOSPITAL   (Belgium)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD2 ANTIGEN; CD3 ANTIGEN; CYTOKINE; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; RECOMBINANT INTERLEUKIN 15; RECOMBINANT INTERLEUKIN 2; T LYMPHOCYTE RECEPTOR;

ADULT; ANTIGEN PRESENTING CELL; ARTICLE; AUTOCRINE EFFECT; CASE REPORT; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HYPEREOSINOPHILIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION;

EID: 0033178502     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v94.3.994.415k26_994_1002     Document Type: Article

References (56)

1. Chusid MJ, Dale DC, West BC, Wolff SM: The hypereosinophilic syndrome: Analysis of fourteen cases with review of the literature. Medicine 54:1, 1975
2. Weller PF, Bubley GJ: The idiopathic hypereosinophilic syndrome. Blood 83:2759, 1994
3. Fauci AS, Harley JB, Roberts WC, Ferrans VJ, Gralnick HR, Bjornson BH: NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations. Ann Intern Med 97:78, 1982
4. Yoo TJ, Orman SV, Patil SR, Dorminey C, Needleman S, Rajtora D, Graves N, Ackerman L, Taylor WW: Evolution to eosinophilic leukemia with a t(5:11) translocation in a patient with idiopathic hypereosinophilic syndrome. Cancer Genet Cytogenet 11:389, 1984
5. Doorduijn JK, van Lom K, Lowenberg B: Eosinophilia and granulocytic dysplasia terminating in acute myeloid leukaemia after 24 years. Br J Haematol 95:531, 1996
6. Weide R, Rieder H, Mehraein Y, Wolf M, Kaiser U, Seifart U, Gorg C, Havemann K: Chronic eosinophilic leukaemia (CEL): A distinct myeloproliferative disease. Br J Haematol 96:117, 1997
7. Luppi M, Marasca R, Morselli M, Barozzi P, Torelli G: Clonal nature of hypereosinophilic syndrome (letter). Blood 84:349, 1994
8. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M: Brief report: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 330:535, 1994
9. Schandene L, Del Prete GF, Cogan E, Stordeur P, Crusiaux A, Kennes B, Romagnani S, Goldman M: Recombinant interferon-alpha selectively inhibits the production of interleukin-5 by human CD4+ T cells. J Clin Invest 97:309, 1996
10. Simon HU, Yousefi S, Dommann-Scherrer CC, Zimmermann DR, Bauer S, Barandun J, Blaser K: Expansion of cytokine-producing CD4-CD8-T cells associated with abnormal Fas expression and hypereosinophilia. J Exp Med 183:1071, 1996
11. Brugnoni D, Airo P, Rossi G, Bettinardi A, Simon HU, Garza L, Tosoni C, Cattaneo R, Blaser K, Tucci A: A case of hypereosinophilic syndrome is associated with the expansion of a CD3-CD4+ T-cell population able to secrete large amounts of interleukin-5 Blood 87:1416, 1996
12. Kitano K, Ichikawa N, Mahbub B, Ueno M, Ito T, Shimodaira S, Kodaira H, Ishida F, Kobayashi H, Saito H, Okubo Y, Enokihara H, Kiyosawa K: Eosinophilia associated with proliferation of CD(3+)4-(8-) alpha beta+ T cells with chromosome 16 anomalies. Br J Haematol 92:315, 1996
13. Gleich GJ, Adolphson CR, Leiferman KM: The biology of the eosinophilic leukocyte. Annu Rev Med 44:85, 1993
14. Wardlaw AJ: Eosinophils in the 1990s: New perspectives on their role in health and disease. Postgrad Med J 70:536, 1994
15. Her E, Frazer J, Austen KF, Owen WF Jr: Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. J Clin Invest 88:1982,1991
16. Simon HU, Blaser K: Inhibition of programmed eosinophil death: A key pathogenic event for eosinophilia? Immunol Today 16:53, 1995
17. Schleimer RP, Sterbinsky SA, Kaiser J, Bickel CA, Klunk DA, Tomioka K, Newman W, Luscinskas FW, Gimbrone MA Jr, McIntyre BW, Bochner BS:: IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol 148:1086, 1992
18. Mosmann TR, Coffman RL: TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145, 1989
19. Romagnani S: Th1 and Th2 in human diseases. Clin Immunol Immunopathol 80:225, 1996
20. Gleich GJ, Schroeter AL, Marcoux JP, Sachs MI, O'Connell EJ, Kohler PF: Episodic angioedema associated with eosinophilia. N Engl J Med 310:1621, 1984
21. Romani N, Reider D, Heuer M, Ebner S, Kampgen E, Eibl B, Niederwieser D, Schuler G: Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196:137, 1996
22. de Waal Malefyt R, Yssel H, Spits H, de Vries JE, Sancho J, Terhorst C, Alarcon B: Human T cell leukemia virus type I prevents cell surface expression of the T cell receptor through down-regulation of the CD3-gamma, -delta, -epsilon, and -zeta genes. J Immunol 145:2297, 1990
23. Willard-Gallo KE, Van de Keere F, Kettmann R: A specific defect in CD3 gamma-chain gene transcription results in loss of T-cell receptor/CD3 expression late after human immunodeficiency virus infection of a CD4+ T-cell line. Proc Natl Acad Sci USA 87:6713, 1990
24. Furukawa M, Yasukawa M, Yakushijin Y, Fujita S: Distinct effects of human herpesvirus 6 and human herpesvirus 7 on surface molecule expression and function of CD4+ T cells. J Immunol 152:5768, 1994
25. Luton F, Buferne M, Davoust J, Schmitt-Verhulst AM, Boyer C: Evidence for protein tyrosine kinase involvement in ligand-induced TCR/CD3 internalization and surface redistribution. J Immunol 153:63, 1994
26. Farace F, Angevin E, Vanderplancke J, Escudier B, Triebel F: The decreased expression of CD3 zeta chains in cancer patients is not reversed by IL-2 administration. Int J Cancer 59:752, 1994
27. Tartour E, Latour S, Mathiot C, Thiounn N, Mosseri V, Joyeux I, D'Enghien CD, Lee R, Debre B, Fridman WH: Variable expression of CD3-zeta chain in tumor-infiltrating lymphocytes (TIL) derived from renal-cell carcinoma: Relationship with TIL phenotype and function. Int J Cancer 63:205, 1995
28. Sanderson CJ: Interleukin-5, eosinophils, and disease. Blood 79:3101, 1992
29. Punnonen J, Yssel H, de Vries JE: The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells. J Allergy Clin Immunol 100:792, 1997
30. Takemoto S, Mulloy JC, Cereseto A, Migone TS, Patel BK, Matsuoka M, Yamaguchi K, Takatsuki K, Kamihira S, White JD, Leonard WJ, Waldmann T, Franchini G: Proliferation of adult T cell leukemia/lymphoma cells is associated with the constitutive activation of JAK/STAT proteins. Proc Natl Acad Sci USA 94:13897, 1997
31. Jenkins MK, Johnson JG: Molecules involved in T-cell costimulation. Curr Opin Immunol 5:361, 1993
32. Verhasselt V, Buelens C, Willems F, De Groote D, Haeffner-Cavaillon N, Goldman M: Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: Evidence for a soluble CD14-dependent pathway. J Immunol 158:2919, 1997
33. O'Garra A: Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 8:275, 1998
34. van Lier RA, Brouwer M, Aarden LA: Signals involved in T cell activation. T cell proliferation induced through the synergistic action of anti-CD28 and anti-CD2 monoclonal antibodies. Eur J Immunol 18:167, 1988
35. Pierres A, Lopez M, Cerdan C, Nunes J, Olive D, Mawas C: Triggering CD 28 molecules synergize with CD 2 (T 11.1 and T 11.2)-mediated T cell activation. Eur J Immunol 18:685, 1988
36. Cerdan C, Martin Y, Brailly H, Courcoul M, Flavetta S, Costello R, Mawas C, Birg F, Olive D: IL-1 alpha is produced by T lymphocytes activated via the CD2 plus CD28 pathways. J Immunol 146:560, 1991
37. Cerdan C, Martin Y, Courcoul M, Brailly H, Mawas C, Birg F, Olive D: Prolonged IL-2 receptor alpha/CD25 expression after T cell activation via the adhesion molecules CD2 and CD28. Demonstration of combined transcriptional and post-transcriptional regulation. J Immunol 149:2255, 1992
38. Cerdan C, Martin Y, Courcoul M, Mawas C, Birg F, Olive D: CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation. J Immunol 154:1007, 1995
39. Costello R, Cerdan C, Pavon C, Brailly H, Hurpin C, Mawas C, Olive D: The CD2 and CD28 adhesion molecules induce long-term autocrine proliferation of CD4+ T cells. Eur J Immunol 23:608, 1993
40. Wood GS, Hong SR, Sasaki DT, Abel EA, Hoppe RT, Warnke RA, Morhenn VB: Leu-8/CD7 antigen expression by CD3+ T cells: Comparative analysis of skin and blood in mycosis fungoides/Sezary syndrome relative to normal blood values. J Am Acad Dermatol 22:602, 1990
41. Bogen SA, Pelley D, Charif M, McCusker M, Koh H, Foss F, Garifallou M, Arkin C, Zucker-Franklin D: Immunophenotypic identification of Sezary cells in peripheral blood. Am J Clin Pathol 106:739, 1996
42. Vowels BR, Cassin M, Vonderheid EC, Rook AH: Aberrant cytokine production by Sezary syndrome patients: Cytokine secretion pattern resembles murine Th2 cells. J Invest Dermatol 99:90, 1992
43. Weinberg JM, Jaworsky C, Benoit BM, Telegan B, Rook AH, Lessin SR: The clonal nature of circulating Sezary cells. Blood 86:4257, 1995
44. McCusker ME, Garifallou M, Bogen SA: Sezary lineage cells can be induced to proliferate via CD28-mediated costimulation. J Immunol 158:4984, 1997
45. Holter W, Majdic O, Kalthoff FS, Knapp W: Regulation of interleukin-4 production in human mononuclear cells. Eur J Immunol 22:2765, 1992
46. King CL, Stupi RJ, Craighead N, June CH, Thyphronitis G: CD28 activation promotes Th2 subset differentiation by human CD4+ cells. Eur J Immunol 25:587, 1995
47. Rulifson IC, Sperling AI, Fields PE, Fitch FW, Bluestone JA: CD28 costimulation promotes the production of Th2 cytokines. J Immunol 158:658, 1997
48. Lenschow DJ, Walunas TL, Bluestone JA: CD28/B7 system of T cell costimulation. Annu Rev Immunol 14:233, 1996
49. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell 80:707, 1995
50. Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS, Gribben JG, Nadler LM: B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2:523, 1995
51. Schweitzer AN, Borriello F, Wong RC, Abbas AK, Sharpe AH: Role of costimulators in T cell differentiation: Studies using antigen-presenting cells lacking expression of CD80 or CD86. J Immunol 158:2713, 1997
52. Natesan M, Razi-Wolf Z, Reiser H: Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. J Immunol 156:2783, 1996
53. Moraillon I, Bagot M, Bournerias I, Prin L, Wechsler J, Revuz J: Hypereosinophilic syndrome with pachyderma preceding lymphoma. Treatment with interferon alpha. Ann Dermatol Venereol 118:883, 1991
54. O'Shea JJ, Jaffe ES, Lane HC, MacDermott RP, Fauci AS: Peripheral T cell lymphoma presenting as hypereosinophilia with vasculitis. Clinical, pathologic, and immunologic features. Am J Med 82:539, 1987
55. Bagot M, Bodemer C, Wechsler J, Divine M, Haioun C, Capesius C, Saal F, Cabotin P, Roubertie E, de Prost Y, Loretta G, Revuz J: Non epidermotropic T lymphoma preceded for several years by hypereosinophilic syndrome. Ann Dermatol Venereol 117:883, 1990
56. Brugnoni D, Airo P, Tosoni C, Taglietti M, Lodi-Rizzini F, Calzavara-Pinton P, Leali C, Cattaneo R: CD3-CD4+ cells with a Th2-like pattern of cytokine production in the peripheral blood of a patient with cutaneous T cell lymphoma. Leukemia 11:1983, 1997